Clinical Performance of Whole-Body 18F-FDG PET/Dixon-VIBE, T1-Weighted…
페이지 정보
본문
Lee SJ, Seo HJ, Kang KW*, Jeong SY*, Yi NJ, Lee JM, Chung JK, Edmund Kim E, Paeng JC, Cheon GJ, Lee DS.
- 이전글Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation. 17.02.16
- 다음글The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative (131) I dose over 37 GBq. 17.02.16
댓글목록
등록된 댓글이 없습니다.